Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Erlotinib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 28 USDMF, 1 JDMF, 16 EU WC, 15 KDMF, 15 NDC API, 31 Listed Suppliers, $ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

70 FDF Dossiers, 41 FDA Orange Book, 3 Europe, 11 Canada, 11 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 29 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 38 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 14 Disintegrants & Superdisintegrants, 14 Granulation, 12 Direct Compression, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 7 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 3 API Stability Enhancers, 3 Chewable & Orodispersible Aids, 2 Emulsifying Agents, 1 Surfactant & Foaming Agents, 1 Solubilizers, 1 Topical, 1 Parenteral

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

3 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Alembic Pharmaceuticals Limited	India	M/sAlembic Pharmaceuticals limited	WC-0082	Erlotinib Hydrochloride IH	2022-06-17	2025-02-07	Karakhadi Plot No. 842-843, At - Karakhdi, Tal. - Padra, Dist - Vadodara 391 450 , Gujarat, India
04/06/2025	BDR Lifesciences	India	M/s BDR lifesciences Pvt Ltd	WC-0340	Erlotinib Hydrochloride IH	2022-09-30	2025-04-14	R.S No: 578, Near Effluent Channel, at & Post: Luna, Taluka: Padra, District: Vadodara-391440, India

Erlotinib Hydrochloride

Erlotinib Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers

28 USDMF

1 JDMF

16 EU WC

15 KDMF

15 NDC API

31 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

70 FDF Dossiers

41 FDA Orange Book

3 Europe

11 Canada

11 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

4 DKSH

3 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

10 Corel Pharma Chem

5 DFE Pharma

5 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

29 Kerry

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

1 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

11 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives

38 Fillers, Diluents & Binders

20 Controlled & Modified Release

14 Disintegrants & Superdisintegrants

14 Granulation

12 Direct Compression

12 Thickeners and Stabilizers

12 Lubricants & Glidants

12 Co-Processed Excipients

7 Film Formers & Plasticizers

6 Taste Masking

5 Empty Capsules

4 Vegetarian Capsules

4 Coloring Agents

4 Rheology Modifiers

3 API Stability Enhancers

3 Chewable & Orodispersible Aids

2 Emulsifying Agents

1 Surfactant & Foaming Agents

1 Solubilizers

TABLET;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons